FI941911A0 - Kondensoidut kinolyylidihydropyridiinit, menetelmä niiden valmistamiseksi ja niiden käyttö lääkeaineissa - Google Patents

Kondensoidut kinolyylidihydropyridiinit, menetelmä niiden valmistamiseksi ja niiden käyttö lääkeaineissa

Info

Publication number
FI941911A0
FI941911A0 FI941911A FI941911A FI941911A0 FI 941911 A0 FI941911 A0 FI 941911A0 FI 941911 A FI941911 A FI 941911A FI 941911 A FI941911 A FI 941911A FI 941911 A0 FI941911 A0 FI 941911A0
Authority
FI
Finland
Prior art keywords
preparation
condensed
dihydropyridines
quinolyl
pharmaceuticals
Prior art date
Application number
FI941911A
Other languages
English (en)
Swedish (sv)
Other versions
FI941911A (fi
Inventor
Siegfried Goldmann
Juergen Stoltefuss
Alexander Straub
Martin Bechem
Rainer Gross
Siegbert Hebisch
Joachim Huetter
Howard-Paul Rounding
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of FI941911A0 publication Critical patent/FI941911A0/fi
Publication of FI941911A publication Critical patent/FI941911A/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/04Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Saccharide Compounds (AREA)
  • Pyridine Compounds (AREA)
FI941911A 1993-04-27 1994-04-25 Kondensoidut kinolyylidihydropyridiinit, menetelmä niiden valmistamiseksi ja niiden käyttö lääkeaineissa FI941911A (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4313690A DE4313690A1 (de) 1993-04-27 1993-04-27 Kondensierte Chinolyl-dihydropyridine, Verfahren zu ihrer Herstellung und ihre Verwendung in Arzneimitteln

Publications (2)

Publication Number Publication Date
FI941911A0 true FI941911A0 (fi) 1994-04-25
FI941911A FI941911A (fi) 1994-10-28

Family

ID=6486449

Family Applications (1)

Application Number Title Priority Date Filing Date
FI941911A FI941911A (fi) 1993-04-27 1994-04-25 Kondensoidut kinolyylidihydropyridiinit, menetelmä niiden valmistamiseksi ja niiden käyttö lääkeaineissa

Country Status (20)

Country Link
US (1) US5436342A (fi)
EP (1) EP0622366B1 (fi)
JP (1) JPH06321939A (fi)
CN (1) CN1098721A (fi)
AT (1) ATE145903T1 (fi)
AU (1) AU5922594A (fi)
CA (1) CA2121980A1 (fi)
CZ (1) CZ99494A3 (fi)
DE (2) DE4313690A1 (fi)
DK (1) DK0622366T3 (fi)
ES (1) ES2096368T3 (fi)
FI (1) FI941911A (fi)
GR (1) GR3022026T3 (fi)
HU (1) HUT70488A (fi)
IL (1) IL109417A0 (fi)
MX (1) MX9403032A (fi)
NO (1) NO941514L (fi)
NZ (1) NZ260383A (fi)
SK (1) SK48094A3 (fi)
ZA (1) ZA942883B (fi)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996014846A1 (en) 1994-11-16 1996-05-23 Synaptic Pharmaceutical Corporation Dihydropyrimidines and uses thereof
US6268369B1 (en) 1994-11-16 2001-07-31 Synaptic Pharmaceutical Corporation 5-(heterocyclic alkyl)-6-aryl-dihydropyrimidines
US6228861B1 (en) 1995-11-16 2001-05-08 Synaptic Pharmaceutical Corporation Dihydropyrimidines and uses thereof
US6172066B1 (en) 1996-05-16 2001-01-09 Synaptic Pharmaceutical Corporation Dihydropyrimidines and uses thereof
US6245773B1 (en) 1996-05-16 2001-06-12 Synaptic Pharmaceutical Corporation 5-(heterocyclic alkyl)-6-aryl-dihydropyrimidines
US6680323B2 (en) 1998-12-23 2004-01-20 Synaptic Pharmaceutical Corporation Dihydropyrimidines and uses thereof
US6274585B1 (en) 1998-12-23 2001-08-14 Synaptic Pharmaceutical Corporation Dihydropyrimidines and uses thereof
US6518279B2 (en) 1999-03-04 2003-02-11 Abbott Laboratories Cyclopentanone dihydropyridine compounds useful as potassium channel openers
US6720324B2 (en) 2000-07-05 2004-04-13 Synaptic Pharmaceutical Corporation Selective melanin concentrating hormone-1 (MCH1) receptor antagonists and uses thereof
AU2004272078A1 (en) * 2003-09-10 2005-03-24 Synta Pharmaceuticals Corp. Dihydropyridine compounds for treating or preventing metabolic disorders
CA2752603C (en) 2009-02-18 2016-04-05 Bayer Pharma Aktiengesellschaft Bi- and tricyclic indazole-substituted 1,4-dihydropyridine derivatives and uses thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1552911A (en) * 1975-07-02 1979-09-19 Fujisawa Pharmaceutical Co 1,4 dihydropyridine derivatives and the preparation thereof
DE2752820A1 (de) * 1977-11-26 1979-05-31 Bayer Ag Neue nitrosubstituierte 1,4-dihydropyridine, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
DE3412947A1 (de) * 1984-04-06 1985-10-17 Bayer Ag, 5090 Leverkusen Tetrahydothienopyridine, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
DE4011105A1 (de) * 1990-04-06 1991-10-10 Bayer Ag Neue 4-chinolyl-dihydropyridine, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln
US5204472A (en) * 1990-04-06 1993-04-20 Bayer Aktiengesellschaft Quinoline and isoquinoline intermediates

Also Published As

Publication number Publication date
DE4313690A1 (de) 1994-11-03
HU9401193D0 (en) 1994-07-28
CZ99494A3 (en) 1995-01-18
ZA942883B (en) 1995-01-16
EP0622366A1 (de) 1994-11-02
FI941911A (fi) 1994-10-28
HUT70488A (en) 1995-10-30
EP0622366B1 (de) 1996-12-04
CN1098721A (zh) 1995-02-15
DK0622366T3 (da) 1997-05-12
SK48094A3 (en) 1994-12-07
JPH06321939A (ja) 1994-11-22
DE59401179D1 (de) 1997-01-16
MX9403032A (es) 1995-01-31
CA2121980A1 (en) 1994-10-28
GR3022026T3 (en) 1997-03-31
AU5922594A (en) 1994-11-03
US5436342A (en) 1995-07-25
ES2096368T3 (es) 1997-03-01
NO941514L (no) 1994-10-28
IL109417A0 (en) 1994-07-31
NO941514D0 (fi) 1994-04-26
NZ260383A (en) 1996-02-27
ATE145903T1 (de) 1996-12-15

Similar Documents

Publication Publication Date Title
HU210714A9 (en) Sulfonamido- and sulfonamidocarbonylpyridine-2-carboxamides and their pyridine-n-oxides, process for their preparation and their use as pharmaceuticals
HUT65689A (en) Process for producing sulfonamides and pharmaceutical preparations containing them
DE68914488T2 (de) 2-(2-Hydroxy-3-phenoxypropylamino)ethylphenoxyacetamide, Verfahren und Zwischenprodukte zu deren Herstellung.
FI941911A0 (fi) Kondensoidut kinolyylidihydropyridiinit, menetelmä niiden valmistamiseksi ja niiden käyttö lääkeaineissa
DK0404283T3 (da) 11alfa-aryl-4-estrener, fremgangsmåde til fremstilling af disse samt deres anvendelse som lægemidler
DK0422485T3 (da) Quinoloncarboxylsyrederivater, fremgangsmåder til deres fremstilling samt deres anvendelse som antivirale midler
ZA94841B (en) Novel derivatives of quinolonecarboxylic acid and naphthyridonecarboxylic acid
ZA944728B (en) alph -amino acid compounds a process for the preparation thereof and pharmaceutical compositions containing them
ATE66209T1 (de) Dihydropyridinamide, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln.
ATE172976T1 (de) 3-aminochroman-spiroderivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen
BR9707004A (pt) Composto processo para preparar o mesmo composição farmacêutica utilização do composto e processos para tratamento de doenças do sistema endocinológico e para a manufatura de um medicamento
DK0410278T3 (da) Reninhæmmende aminooligohydroxyderivater
ATE158576T1 (de) Alpha-aryl-alpha-hydroxy-beta- imidazolinylpropionsäureamide
NO993126D0 (no) Anvendelse av benzoylalkyl-1,2,3,6-tetrahydropyridiner
IL111922A (en) Isopropyl 2-methoxyethyl 4-(2-chloro-3-cyano-phenyl)-1,4-dihydro-2,6-dimethyl-pyridine-3,5-dicarboxylates their preparation and pharmaceutical compositions containing them